Why the study?
Does transitional care reduce readmission in patients with chronic obstructive pulmonary disease?
Population
1879 participants with chronic obstructive pulmonary disease (COPD) from 7 RCTs
Comparison
Transitional care vs Control group
Design
Meta-analysis
Follow-up
up to 2 years (6 and 18 month time points reported)
Key result
Transitional care significantly reduced readmission for COPD at 6 months (RR 0.51; 95% CI 0.38-0.68; P<0.00001) and 18 months, as well as all-cause readmission at 18 months.
Authors
Loading...
Supports implementation of transitional care after COPD exacerbation; strengthens pooled evidence for readmission reduction persisting to 18 months.
Meta-Analysis (n=1,879)
Does transitional care reduce readmission in patients with chronic obstructive pulmonary disease?
Relative Risk: 0.51 (95% CI 0.38–0.68)
p-value: p=<0.00001
Transitional care significantly reduces COPD-specific and all-cause readmissions up to 18 months, though the effect weakens over time.
Liu et al. (2017) conducted a meta-analysis in Chronic obstructive pulmonary disease (COPD) (n=1,879). Transitional care vs. Control was evaluated on Readmission for COPD at 6 months (RR 0.51, 95% CI 0.38-0.68, p=<0.00001). Transitional care significantly reduced readmission for COPD at 6 months (RR 0.51; 95% CI 0.38-0.68; P<0.00001) and 18 months, as well as all-cause readmission at 18 months.